Semnur Pharmaceuticals (SMNR) Interest & Investment Income (2022 - 2025)
Semnur Pharmaceuticals (SMNR) reported Interest & Investment Income of $18,080 for Q2 2025, down 97.2% from $640,157 a year earlier and down 77.1% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Interest & Investment Income (2022 - 2025) Analysis & Trends
Over the twelve months ended Jun 30, 2025, Semnur Pharmaceuticals' Interest & Investment Income came in at $381,051, down 88.1% year-over-year; for FY2024, it came in at $1.58 million, down 58.9% from FY2023.
- By year, Interest & Investment Income came in at $3.84 million in FY2023 (+214.6%) and $1.22 million in FY2022.
- The Q2 2025 figure ranks as the lowest quarterly Interest & Investment Income in data going back to Q2 2022.
- Year over year, Interest & Investment Income has now declined in each of the last six quarters, with an average decline of 27.0% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2023 (growth of 793.4%); the low point was Q2 2025 (a decline of 97.2%).
- Per Business Quant data, the three quarters before Q2 2025 came in at $78,971 (Q1 2025), $86,722 (Q4 2024) and $197,278 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 18,080.00 |
| Mar 31, 2025 | 78,971.00 |
| Dec 31, 2024 | 86,722.00 |
| Sep 30, 2024 | 197,278.00 |
| Jun 30, 2024 | 640,157.00 |
| Mar 31, 2024 | 653,885.00 |
| Dec 31, 2023 | 753,537.00 |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 912,646.00 |
| Dec 31, 2022 | 726,339.00 |
| Sep 30, 2022 | 380,429.00 |
| Jun 30, 2022 | 114,831.00 |
API Access
Semnur Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();